Sep 11, 2019 - Ultragenyx (RARE) and partner Kyowa Kirin plan to submit an sBLA to the FDA for the label expansion of Crysvita.
Sep 11, 2019 - Key highlights of the past week include regulatory and pipeline updates, and licensing deals and more.
Sep 10, 2019 - Adaptimmune Therapeutics (ADAP) gets Orphan Drug Designation for SPEAR T-cells targeting MAGE-A4 (ADP-A2M4 program) for the treatment of soft tissue sarcomas.
Sep 10, 2019 - Horizon (HZNP) announces the FDA has accepted the Biologics License Application (BLA) for teprotumumab, for the treatment of active thyroid eye disease, and granted it Priority Review designation.
Sep 10, 2019 - Companies In The News Are: T,AA,AMGN,BA
Sep 09, 2019 - The following slide deck was published by Amgen Inc. in conjunction with this event.
Sep 09, 2019 - Novartis' (NVS) migraine drug Aimovig is effective and safe in treating patients with episodic migraine in a long-term study.
Sep 06, 2019 - Amgen is acquiring Otezla, and The Medicines Company unveils stellar data for its cholesterol treatment.
Sep 05, 2019 - Two presentations at the World Conference on Lung Cancer will make a big difference for at least four different drugmakers.
Sep 05, 2019 - Merck's (MRK) label expansion application for Keytruda in combination with Pfizer's Inlyta for the first-line treatment of renal cell carcinoma gets approval in Europe.